The Recall Desk
ModerateFDA (Drugs)·D-0860-2017·Announced 2017-05-31

Mylan Recalls Tarina Fe 1/20 Tablets Due to Chemical Contamination

Mylan Pharmaceuticals is recalling Tarina Fe 1/20 tablets due to chemical contamination from paint thinner vapors during manufacturing.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which indicates the use of, or exposure to, the product is not likely to cause adverse health consequences. The hazard is a chemical contamination from paint thinner vapors, which is a low-risk contamination issue without reported illnesses.

Plain-English summary

Mylan Pharmaceuticals Inc. is recalling 43,848 cartons of Tarina Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets). The affected product is identified by Lot # 6843F002D with an expiration date of 02/18. The product was distributed nationwide in the USA.

The recall was initiated because out-of-specification results for impurities were found in the product. The contamination was determined to be the result of vapors associated with paint thinner used in the repair of the manufacturing room.

Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for further instructions. The product is prescription-only and was manufactured for Afaxys, Inc.

The recalled product

Product
Tarina Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 blister pack containing 28 tablets (NDC 50102-128-01), packaged in 3 pouches, each pouch contains one blister pack of 28 tablets (NDC 50102-128-03), Rx only, Manufactured for
Manufacturer
Mylan Pharmaceuticals Inc.
Category
Drug — Oral Contraceptive
Hazard
Affected units
43,848

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 6843F002D
  • Exp 02/18

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Mylan Pharmaceuticals Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Mylan Pharmaceuticals Inc.

See all →

Same hazard · chemical contamination

See all →